Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. usa massachusetts
  4. bacterial strains
Show results for
Products

Companies


Refine by
Locations
Back to All Locations

  • USA
  • Massachusetts
Brands

  • finch
  • seres
  • vedanta
Applications

  • Microbiome Therapeutics for Clinical Trials
  • Microbiome Therapeutics for Patients and Physicians

Bacterial Strains Equipment Supplied In Usa Massachusetts

3 equipment items found
In MassachusettsAvailable In MassachusettsNear Massachusetts

Seres - Model SER-301 - Investigational, Oral, Rationally-Designed, Fermented Microbiome Therapeutic Ulcerative Colitis

Seres - Model SER-301 - Investigational, Oral, Rationally-Designed, Fermented Microbiome Therapeutic Ulcerative Colitis

Manufactured by:Seres Therapeutics, Inc.   based inCambridge, MASSACHUSETTS (USA)
SER-301 is an investigational, oral, rationally-designed, fermented microbiome therapeutic for the treatment of mild-to-moderate ulcerative colitis (UC). SER-301 is a consortium of multiple bacterial strains that is manufactured by fermenting each strain individually and then combining to form drug product. ...
CONTACT SUPPLIER

Vedanta - Model VE416 - Orally Administered Rationally-Defined Bacterial Drug

Vedanta - Model VE416 - Orally Administered Rationally-Defined Bacterial Drug

Manufactured by:Vedanta Biosciences, Inc   based inCambridge, MASSACHUSETTS (USA)
VE416 is an orally administered rationally-defined bacterial consortium candidate being developed for the potential treatment of food allergy. VE416 consists of clonal human commensal bacterial strains selected for their ability to suppress allergic responses and manufactured under cGMP conditions. It is produced from pure, non-pathogenic clonal ...
CONTACT SUPPLIER

Finch - Model TAK-524 & FIN-525 - Microbiome Therapeutics for Inflammatory Bowel Disease (IBD)

Finch - Model TAK-524 & FIN-525 - Microbiome Therapeutics for Inflammatory Bowel Disease (IBD)

Manufactured by:Finch Therapeutics Group, Inc.   based inSomerville, MASSACHUSETTS (USA)
In collaboration with Takeda Pharmaceuticals, we are developing FIN-524 and FIN-525, orally administered, Targeted Consortia product candidates designed for the treatment of ulcerative colitis (UC) and Crohn’s disease (CD), respectively. UC and CD are the two most common types of IBD, an autoimmune condition that causes inflammation of the gastrointestinal (GI) ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT